Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-012991
Filing Date
2022-03-31
Accepted
2022-03-31 20:15:32
Documents
1
Period of Report
2022-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 22830
  Complete submission text file 0000899243-22-012991.txt   24171
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Issuer) CIK: 0001880438 (see all company filings)

EIN.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3835 CLEGHORN AVENUE, SUITE 300 NASHVILLE TN 37215
Business Address
Readnour Robin Shane (Reporting) CIK: 0001914883 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41331 | Film No.: 22795201